Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
administered, Akathisia, Assessment, Awardee, baseline, blood, bodyweight, CGI, cognition, daily, dopamine, employed, endocrine, endpoint, extension, extrapyramidal, Factor, fixed, forecasted, functioning, glucose, hormone, impression, ISSUER, label, Low, lt, Marder, meaningful, mg, modulator, NDA, NS, numerically, OLE, open, partially, Personal, profile, prolactin, reached, readout, Recent, recently, reduction, REFRESH, score, secondary, serotonin, signaling, social, statistical, statistically, submission, superior, symptom, Syndrome, thyroid, today, tolerability, week
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view